These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9718276)

  • 21. [3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.
    Wainscott DB; Krushinski JH; Audia JE; Schaus JM; Zgombick JM; Lucaites VL; Nelson DL
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Mar; 371(3):169-77. PubMed ID: 15900510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
    Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GR127935 acts as a partial agonist at recombinant human 5-HT1D alpha and 5-HT1D beta receptors.
    Watson JM; Burton MJ; Price GW; Jones BJ; Middlemiss DN
    Eur J Pharmacol; 1996 Oct; 314(3):365-72. PubMed ID: 8957260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
    Newman-Tancredi A; Gavaudan S; Conte C; Chaput C; Touzard M; Verrièle L; Audinot V; Millan MJ
    Eur J Pharmacol; 1998 Aug; 355(2-3):245-56. PubMed ID: 9760039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
    Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
    Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning and characterization of the guinea pig 5-HT1F receptor subtype: a comparison of the pharmacological profile to the human species homolog.
    Adham N; Bard JA; Zgombick JM; Durkin MM; Kucharewicz S; Weinshank RL; Branchek TA
    Neuropharmacology; 1997; 36(4-5):569-76. PubMed ID: 9225282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.
    Nonno R; Pannacci M; Lucini V; Angeloni D; Fraschini F; Stankov BM
    Br J Pharmacol; 1999 Jul; 127(5):1288-94. PubMed ID: 10455277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin5 receptor-mediated [35S]guanosine-5'-O-(3-thio)triphosphate binding: agonist potencies and the influence of sodium chloride on intrinsic activity.
    Williams AJ; Michel AD; Feniuk W; Humphrey PP
    Mol Pharmacol; 1997 Jun; 51(6):1060-9. PubMed ID: 9187273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of type 1alpha metabotropic glutamate receptor-stimulated [35S]-GTPgammaS binding.
    Akam EC; Carruthers AM; Nahorski SR; Challiss RA
    Br J Pharmacol; 1997 Jul; 121(6):1203-9. PubMed ID: 9249258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
    Yu XJ; Waeber C; Castanon N; Scearce K; Hen R; Macor JE; Chauveau J; Moskowitz MA
    Mol Pharmacol; 1996 May; 49(5):761-5. PubMed ID: 8622623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor.
    Bhalla P; Sharma HS; Ma X; Wurch T; Pauwels PJ; Saxena PR
    Br J Pharmacol; 2001 Jul; 133(6):891-901. PubMed ID: 11454663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective heterologous regulation of 5-HT1A receptor-stimulated 35S GTPgammaS binding in the anterior cingulate cortex as a result of 5-HT2 receptor activation.
    Valdez M; Burke TF; Hensler JG
    Brain Res; 2002 Dec; 957(1):174-82. PubMed ID: 12443993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
    Ahlgren C; Eriksson A; Tellefors P; Ross SB; Stenfors C; Malmberg A
    Eur J Pharmacol; 2004 Sep; 499(1-2):67-75. PubMed ID: 15363952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of [35S]GTPgammaS stimulated by (+)-pentazocine sigma receptor agonist, is abundant in the guinea pig spleen.
    Maruo J; Yoshida A; Shimohira I; Matsuno K; Mita S; Ueda H
    Life Sci; 2000 Jun; 67(5):599-603. PubMed ID: 10993125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HT1F receptor agonists in acute migraine treatment: a hypothesis.
    Ramadan NM; Skljarevski V; Phebus LA; Johnson KW
    Cephalalgia; 2003 Oct; 23(8):776-85. PubMed ID: 14510923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
    Gupta P; Butler P; Shepperson NB; McHarg A
    Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking.
    Cussac D; Newman-Tancredi A; Duqueyroix D; Pasteau V; Millan MJ
    Mol Pharmacol; 2002 Sep; 62(3):578-89. PubMed ID: 12181434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
    Olianas MC; Concas D; Onali P
    Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.